1
|
Imboden MT, Wolfe E, Evers K, Ferrão A, Mochari-Greenberger H, Johnson S, Kirsten W, Seaverson ELD. Evaluating Workforce Mental Health and Well-Being: A Review of Assessments. Am J Health Promot 2024; 38:540-559. [PMID: 38153034 DOI: 10.1177/08901171231223786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2023]
Abstract
OBJECTIVE Given the importance of mental health and well-being assessments to employers' efforts to optimize employee health and well-being, this paper reviews mental health assessments that have utility in the workplace. DATA SOURCE A review of publicly available mental health and well-being assessments was conducted with a primary focus on burnout, general mental health and well-being, loneliness, psychological safety, resilience, and stress. INCLUSION CRITERIA Assessments had to be validated for adult populations; available in English as a stand-alone tool; have utility in an employer setting; and not have a primary purpose of diagnosing a mental health condition. DATA EXTRACTION All assessments were reviewed by a minimum of two expert reviewers to document number of questions, subscales, fee structure, international use, translations available, scoring/reporting, respondent (ie, employee or organization), and the target of the assessment (ie, mental health domain and organizational or individual level assessments. DATA SYNTHESIS & RESULTS Sixty-six assessments across the six focus areas met inclusion criteria, enabling employers to select assessments that meet their self-identified measurement needs. CONCLUSION This review provides employers with resources that can help them understand their workforce's mental health and well-being status across multiple domains, which can serve as a needs assessment, facilitate strategic planning of mental health and well-being initiatives, and optimize evaluation efforts.
Collapse
Affiliation(s)
- Mary T Imboden
- Health Enhancement Research Organization (HERO), Raleigh, NC, USA
- George Fox University, Newberg, OR, USA
| | - Emily Wolfe
- Health Enhancement Research Organization (HERO), Raleigh, NC, USA
| | - Kerry Evers
- Pro-Change Behavior Systems Inc, South Kingstown, RI, USA
| | - Arline Ferrão
- Independent Social and Organizational Psychologist, Maputo, Mozambique
| | | | - Sara Johnson
- Health Enhancement Research Organization (HERO), Raleigh, NC, USA
- Pro-Change Behavior Systems Inc, South Kingstown, RI, USA
| | - Wolf Kirsten
- International Health Consulting, Tucson, AZ, USA
| | | |
Collapse
|
2
|
Limão R, Spínola Santos A, Araújo L, Cosme J, Inácio F, Tomaz E, Ferrão A, Santos N, Sokolova A, Môrete A, Falcão H, Cunha L, Ferreira A, Bras A, Ribeiro F, Lozoya C, Leiria Pinto P, Prates S, Plácido J, Coimbra A, Taborda-Barata L, Pereira Santos MC, Pereira Barbosa M, Pineda F. Molecular Sensitization Profile to Dermatophagoides pteronyssinus Dust Mite in Portugal. J Investig Allergol Clin Immunol 2020; 32:33-39. [PMID: 32732183 DOI: 10.18176/jiaci.0533] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
OBJECTIVE To analyze component resolved diagnosis to Dermatophagoides pteronyssinus (Der p) in patients with respiratory allergy and its relationship with clinical severity in different geographical areas. METHODS 217 patients (mean age 25.85±12.7 years; 51.16% females) were included, selected from 13 centers in Portugal (5 from North, n=65). All had allergic rhinitis, with or without asthma, and had positive skin prick tests to at least one dust mite. Specific IgE (sIgE) to Der p, Dermatophagoides farinae, Lepidoglyphus destructor, Der p1, Der p 2, Der p 10 and Der p 23 were determined by ImmunoCAP. Statistical analysis (Mann Whitney U test) compared patients with rhinitis vs rhinitis and asthma; mild vsmoderate-to-severe rhinitis; North vs South. RESULTS Prevalence of sensitization was 98.2% to Der p, and 72.4%, 89.4%, 9.7% and 77% to Der p 1, Der p 2, Der p 10 and Der p 23, respectively. Corresponding median sIgE levelswere 8.56, 17.7, 0.01 and 3.95 kUA/L. sIgE to all allergens was higher in patients with moderate-to-severe rhinitis and rhinitis with asthma but not statistically significant (NSS). sIgE to Der p 2 was significantly higher in the South when compared with the North (p=0.0496). CONCLUSIONS sensitization to Der p is the most common in Portugal. Der p 2 had the highest prevalence and median sIgE levels. All sIgE to molecular components were higher in more symptomatic patients (NSS). sIgE to Der p 2 was higher in the South, which may be related to the warmer temperature and/or the larger sample size.
Collapse
Affiliation(s)
- R Limão
- Immunoallergology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Portugal.,Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal
| | - A Spínola Santos
- Immunoallergology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Portugal.,Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal
| | - L Araújo
- Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal.,Immunoallergology Department, Faculdade de Medicina da Universidade do Porto, Portugal
| | - J Cosme
- Immunoallergology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Portugal.,Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal
| | - F Inácio
- Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal.,Immunoallergology Department, Hospital de São Bernardo, Setúbal, Portugal
| | - E Tomaz
- Immunoallergology Department, Hospital de São Bernardo, Setúbal, Portugal
| | - A Ferrão
- Immunoallergology Unit, Hospital do Espírito Santo de Évora, Portugal
| | - N Santos
- Immunoallergology Unit, Hospital de Portimão, Centro Hospitalar Universitário do Algarve, Portugal
| | - A Sokolova
- Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal.,Immunoallergology Unit, Hospital Professor Doutor Fernando Fonseca, Amadora-Sintra, Portugal
| | - A Môrete
- Immunoallergology Unit, Hospital de Aveiro, Centro Hospitalar Baixo Vouga, Portugal
| | - H Falcão
- Immunoallergology Department, Hospital de Santo António, Centro Hospitalar do Porto, Portugal
| | - L Cunha
- Immunoallergology Department, Hospital de Santo António, Centro Hospitalar do Porto, Portugal
| | - A Ferreira
- Immunoallergology Unit, Hospital das Forças Armadas, Lisboa, Portugal
| | - A Bras
- Immunoallergology Unit, Hospital de Faro, Centro Hospitalar Universitário do Algarve, Portugal
| | - F Ribeiro
- Immunoallergology Unit, Hospital de Faro, Centro Hospitalar Universitário do Algarve, Portugal
| | - C Lozoya
- Immunoallergology Unit, Unidade Local de Saúde de Castelo Branco, Portugal
| | - P Leiria Pinto
- Immunoallergology Department, Hospital Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central, Portugal
| | - S Prates
- Immunoallergology Department, Hospital Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central, Portugal
| | - J Plácido
- Immunoallergology Department, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - A Coimbra
- Immunoallergology Department, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - L Taborda-Barata
- Immunoallergology Department, Centro Hospitalar Universitário Cova da Beira, Covilhã, Portugal
| | - M C Pereira Santos
- Allergen and Immunotherapy Interest Group, Sociedade Portuguesa de Alergologia e Imunologia Clínica, Portugal.,Clinical Immunology Laboratory, Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Portugal
| | - M Pereira Barbosa
- Immunoallergology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Portugal.,Clinical Immunology Laboratory, Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Portugal.,University Clinic of Immunoallergology, Faculdade de Medicina da Universidade de Lisboa, Portugal
| | - F Pineda
- Diater Laboratorio de Diagnostico y Aplicaciones Terapeuticas SA, Madrid, Spain
| |
Collapse
|